Fresh Tracks Therapeutics Inc (OTCPK:FRTX)
$ 0.74 -0.005 (-0.67%) Market Cap: 4.45 Mil Enterprise Value: -4.51 Mil PE Ratio: 0 PB Ratio: 0.45 GF Score: 52/100

Q2 2020 Brickell Biotech Inc Earnings Call Transcript

Aug 12, 2020 / 08:30PM GMT
Release Date Price: $40.01 (+0.54%)
Operator

Greetings, and welcome to the Brickell Biotech, Inc. Second Quarter 2020 Financial Results Call. (Operator Instructions) As a reminder, this conference is being recorded.

It is now my pleasure to introduce your host, Dan Ferry of LifeSci Advisors. Thank you, Mr. Ferry. You may begin.

Daniel Ferry
LifeSci Advisors, LLC - MD & Relationship Manager

Thank you, and good afternoon, everyone. Joining me on today's call are Brickell's Chief Executive Officer, Rob Brown; Chief Financial Officer, Mike Carruthers; Chief R&D Officer, Deepak Chadha; and Co-Founder and Chief Operating Officer, Andy Sklawer.

Before we begin, I would like to remind everyone that this conference call and webcast will contain forward-looking statements about the company. These statements are subject to risks and uncertainties that could cause actual results to differ. Please note that these forward-looking statements reflect our opinions only as of the date of this call. We will not undertake obligation to revise or publicly rerelease the results of any revisions to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot